Blood Clots & COVID Vaccines: What They Didn’t Want You to Know

The terrifying reports keep rolling in…

Organ failure, heart damage, and even death.

Now, researchers have identified the chain reaction that triggered deadly blood clots in some recipients of the COVID-19 vaccine.

And yet, in the early days, anyone who dared hesitate against the vaccine was GASLIT and labeled a villain.

We were told the benefits outweighed the risks… and that some of the risks weren’t real at all.

But what about all of the people who have suffered?

And could someone like you have been vulnerable without ever knowing it?

When the first reports of unusual blood clots began surfacing after certain COVID-19 vaccines, officials emphasized how rare they were.

In many cases, people were told the events were coincidental. Statistical noise. That they had nothing to do with vaccine itself.

But the cases kept appearing.

Eventually, researchers identified a real condition: vaccine-induced immune thrombotic thrombocytopenia (VITT), a clotting disorder involving antibodies that activate platelets and trigger dangerous clot formation.

But they didn’t know exactly what caused it.

Now, new research published in The New England Journal of Medicine earlier this month is explaining how this happened at a biological level.

And the mechanism shows that anyone who hasn’t undergone exhaustive clinical genetic testing could be at risk…

So most of us.

Scientists discovered that in people with certain genetic traits, the vaccine could accidentally confuse the immune system.

Instead of simply building protection, the body created antibodies that targeted one of its own blood proteins — platelet factor 4.

When those antibodies latched onto that protein, they flipped on the body’s clotting cells like a switch.

The result?

An aggressive clotting reaction, even as platelet levels dropped.

In other words, the immune system wasn’t attacking a virus — it was attacking part of the body’s own clotting machinery.

Understanding this chain reaction explains how it happened, and may help researchers design safer vaccines or identify higher-risk individuals in the future.

But for those who experienced it, that knowledge may feel like too little, too late.

Over time, agencies have updated warnings. Some vaccines were paused or restricted in certain age groups. And doctors learned how to recognize and treat VITT.

But this event raises larger questions about risk communication.

When something new appears, transparency matters. Acknowledging uncertainty matters.

Public trust depends on it.

And while the incidents were rare, rare does not mean imaginary.

When it comes to your health, you deserve full transparency about both benefits and risks even when those risks are uncommon.

Before getting ANY vaccine or starting any new medication, ask questions.

What are the ingredients?  Is this safe for my age group?

Is it safe in combination with my other medications?

What are the side effects, no matter how rare?

If you ever feel dismissed or pressured, seek a second opinion.

Because informed consent only works when the information is complete.

To knowing better,

Ray Thatcher
Research Director, Health Sciences Institute

Sources:

• Maiese A, Baronti A, Manetti AC, Di Paolo M, Turillazzi E, Frati P, Fineschi V. Death after the Administration of COVID-19 Vaccines Approved by EMA: Has a Causal Relationship Been Demonstrated? Vaccines (Basel). 2022 Feb 16;10(2):308. doi: 10.3390/vaccines10020308. PMID: 35214765; PMCID: PMC8875435.
• Wang, J. J., Schönborn, L., Warkentin, T. E., Müller, L., Thiele, T., Ulm, L., Völker, U., … Greinacher, A. (2026). Adenoviral inciting antigen and somatic hypermutation in VITT. New England Journal of Medicine, 394(7), 669–683. https://doi.org/10.1056/NEJMoa2514824